{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T14:16:09Z","timestamp":1785507369297,"version":"3.56.0"},"reference-count":89,"publisher":"MDPI AG","issue":"15","license":[{"start":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T00:00:00Z","timestamp":1785456000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biology"],"abstract":"<jats:p>Cardiovascular diseases (CVDs) remain the foremost cause of death globally, responsible for 19.2 million deaths and 437 million disability-adjusted life years in 2023, with prevalent cases having more than doubled since 1990. No approved therapy restores myocardium lost to infarction. The adult heart replaces cardiomyocytes at approximately 1% per year in young adults, declining to about 0.45% per year with ageing, far below what is needed to recover the more than one billion cells destroyed by a large myocardial infarction. Cell-based regenerative strategies have been investigated for more than two decades, encompassing bone marrow mononuclear cells (BM-MNCs), mesenchymal stromal cells (MSCs), cardiac progenitor cells, cardiosphere-derived cells (CDCs), skeletal myoblasts, and induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs). Safety has been consistent. Efficacy has been modest and variable: the CADUCEUS trial demonstrated scar mass reduction with CDCs without proportionate ejection fraction improvement; the Phase 1\/2 POSEIDON trial confirmed MSC safety in 30 patients; and the Phase 3 DREAM-HF trial, enrolling 537 patients, failed its primary endpoint (HR 1.2, p = 0.406). Mechanistic work has established that transplanted cells engraft poorly and exert their benefit principally through paracrine signalling mediated by secreted extracellular vesicles and exosomes carrying microRNAs, trophic factors, and immunomodulatory proteins. For iPSC-CMs, electrophysiological immaturity and arrhythmogenic risk in primate models remain unresolved barriers. Emerging strategies include CRISPR-engineered hypoimmune iPSC lines, bioengineered cardiac patches, injectable hydrogel scaffolds, and engineered exosome platforms. This review provides a comprehensive synthesis of preclinical and clinical evidence, examines translational barriers, and identifies the scientific and regulatory priorities required before these therapies can enter routine clinical practice.<\/jats:p>","DOI":"10.3390\/biology15151260","type":"journal-article","created":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T13:23:20Z","timestamp":1785504200000},"page":"1260","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Cell-Based Therapies for Cardiac and Vascular Regeneration in Cardiovascular Disease: Recent Advances, Translational Barriers, and Future Directions"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6620-950X","authenticated-orcid":false,"given":"Sayan","family":"Paul","sequence":"first","affiliation":[{"name":"Department of Microbiology and Immunology, University of Texas Medical Branch at Galveston, Galveston, TX 77555, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raj","family":"Wasnik","sequence":"additional","affiliation":[{"name":"Department of Biotechnology, School of Life Sciences, Pondicherry University, Puducherry 605014, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0751-5491","authenticated-orcid":false,"given":"Ranjith","family":"Kumavath","sequence":"additional","affiliation":[{"name":"Department of Biotechnology, School of Life Sciences, Pondicherry University, Puducherry 605014, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6975-8096","authenticated-orcid":false,"given":"Tungki Pratama","family":"Umar","sequence":"additional","affiliation":[{"name":"UCL Centre for Nanotechnology and Regenerative Medicine, Division of Surgery and Interventional Science, University College London, London WC1E 6BT, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,7,31]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"GBD Cardiovascular Collaborators (2025). Global, Regional, and National Burden of Cardiovascular Diseases and Risk Factors in 204 Countries and Territories, 1990\u20132023. J. Am. Coll. Cardiol., 86, 2167\u20132243.","DOI":"10.2139\/ssrn.5392535"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"3","DOI":"10.54393\/pbmj.v7i02.1034","article-title":"Risk factors associated with cardiovascular disorders","volume":"7","author":"Hussain","year":"2024","journal-title":"Pak. Biomed. J."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1126\/science.1164680","article-title":"Evidence for Cardiomyocyte Renewal in Humans","volume":"324","author":"Bergmann","year":"2009","journal-title":"Science"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"e000016","DOI":"10.1136\/openhrt-2013-000016","article-title":"Blood vessel repair and regeneration in the ischaemic heart","volume":"1","author":"Zhang","year":"2014","journal-title":"Open Heart"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Netala, V.R., Teertam, S.K., Li, H., and Zhang, Z. (2024). A Comprehensive Review of Cardiovascular Disease Management: Cardiac Biomarkers, Imaging Modalities, Pharmacotherapy, Surgical Interventions, and Herbal Remedies. Cells, 13.","DOI":"10.3390\/cells13171471"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1161\/CIRCULATIONAHA.118.033648","article-title":"Neonatal Heart Regeneration: Comprehensive Literature Review","volume":"138","author":"Lam","year":"2018","journal-title":"Circulation"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"3105","DOI":"10.1016\/j.celrep.2020.02.034","article-title":"Direct Comparison of Mononucleated and Binucleated Cardiomyocytes Reveals Molecular Mechanisms Underlying Distinct Proliferative Competencies","volume":"30","author":"Windmueller","year":"2020","journal-title":"Cell Rep."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/nature12054","article-title":"Meis1 regulates postnatal cardiomyocyte cell cycle arrest","volume":"497","author":"Mahmoud","year":"2013","journal-title":"Nature"},{"key":"ref_9","first-page":"53","article-title":"O regeneratsii miokarda plodov i novorozhdennykh krolikov [Regeneration of the myocardium of fetuses and newborn rabbits]","volume":"39","author":"Malyshev","year":"1977","journal-title":"Arkhiv Patol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1038\/nature24045","article-title":"Hippo pathway deficiency reverses systolic heart failure after infarction","volume":"550","author":"Leach","year":"2017","journal-title":"Nature"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1161\/CIRCULATIONAHA.121.054846","article-title":"Adrenergic-Thyroid Hormone Interactions Drive Postnatal Thermogenesis and Loss of Mammalian Heart Regenerative Capacity","volume":"144","author":"Payumo","year":"2021","journal-title":"Circulation"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/35070587","article-title":"Bone marrow cells regenerate infarcted myocardium","volume":"410","author":"Orlic","year":"2001","journal-title":"Nature"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1038\/nature02446","article-title":"Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts","volume":"428","author":"Murry","year":"2004","journal-title":"Nature"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.jacc.2022.11.061","article-title":"Randomized Trial of Targeted Transendocardial Mesenchymal Precursor Cell Therapy in Patients with Heart Failure","volume":"81","author":"Perin","year":"2023","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.reth.2025.09.009","article-title":"A comprehensive review of clinical trials and progress in stem cell therapies for advanced heart failure","volume":"30","author":"Tran","year":"2025","journal-title":"Regen. Ther."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1056\/NEJMoa060186","article-title":"Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction (REPAIR-AMI)","volume":"355","author":"Schachinger","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/S0140-6736(12)60195-0","article-title":"Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): A prospective, randomised phase 1 trial","volume":"379","author":"Makkar","year":"2012","journal-title":"Lancet"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1001\/jama.2012.25321","article-title":"Comparison of Allogeneic vs Autologous Bone Marrow-Derived Mesenchymal Stem Cells Delivered by Transendocardial Injection in Patients with Ischemic Cardiomyopathy: The POSEIDON Randomized Trial","volume":"308","author":"Hare","year":"2012","journal-title":"JAMA"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.yjmcc.2010.08.005","article-title":"Paracrine mechanisms of stem cell reparative and regenerative actions in the heart","volume":"50","author":"Mirotsou","year":"2011","journal-title":"J. Mol. Cell. Cardiol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/s41587-023-01784-x","article-title":"Hypoimmune induced pluripotent stem cells survive long term in fully immunocompetent, allogeneic rhesus macaques","volume":"42","author":"Hu","year":"2024","journal-title":"Nat. Biotechnol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1161\/CIRCULATIONAHA.123.065005","article-title":"Inhalable Stem Cell Exosomes Promote Heart Repair After Myocardial Infarction","volume":"150","author":"Li","year":"2024","journal-title":"Circulation"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.devcel.2020.02.019","article-title":"Dynamic transcriptional responses to injury of regenerative and non-regenerative cardiomyocytes revealed by single-nucleus RNA sequencing","volume":"53","author":"Cui","year":"2020","journal-title":"Dev. Cell"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1016\/j.stem.2025.08.015","article-title":"Targeting lysozyme 2 in endocardium promotes rapid recovery by modulating remote injury signals","volume":"32","author":"Fan","year":"2025","journal-title":"Cell Stem Cell"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Kgabeng, T., Wang, L., Ngwangwa, H.M., and Pandelani, T. (2025). Integrating Spatial Omics and Deep Learning: Toward Predictive Models of Cardiomyocyte Differentiation Efficiency. Bioengineering, 12.","DOI":"10.3390\/bioengineering12101037"},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Kodera, S., and Takeda, N. (2026). From DNA to drug discovery: AI models for cardiovascular precision medicine. J. Cardiol., Online ahead of print.","DOI":"10.1016\/j.jjcc.2026.06.007"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/s41419-024-06703-9","article-title":"Modeling acute myocardial infarction and cardiac fibrosis using human induced pluripotent stem cell-derived multi-cellular heart organoids","volume":"15","author":"Song","year":"2024","journal-title":"Cell Death Dis."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Leung, M.C., and Laksman, Z. (2025). 3D Bioprinting Functional Engineered Heart Tissues. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms262110707"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0140-6736(00)03617-5","article-title":"Myoblast transplantation for heart failure","volume":"357","author":"Scorsin","year":"2001","journal-title":"Lancet"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1161\/CIRCULATIONAHA.107.734103","article-title":"The Myoblast Autologous Grafting in Ischemic Cardiomyopathy (MAGIC) Trial: First Randomized Placebo-Controlled Study of Myoblast Transplantation","volume":"117","author":"Alfieri","year":"2008","journal-title":"Circulation"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1161\/CIRCRESAHA.111.245993","article-title":"Intramyocardial, Autologous CD34+ Cell Therapy for Refractory Angina","volume":"109","author":"Losordo","year":"2011","journal-title":"Circ. Res."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/nm0405-367","article-title":"Paracrine Action Accounts for Marked Protection of Ischemic Heart by Akt-Modified Mesenchymal Stem Cells","volume":"11","author":"Gnecchi","year":"2005","journal-title":"Nat. Med."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1093\/cvr\/cvr053","article-title":"VEGF\/SDF-1 Promotes Cardiac Stem Cell Mobilization and Myocardial Repair in the Infarcted Heart","volume":"91","author":"Tang","year":"2011","journal-title":"Cardiovasc. Res."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.scr.2009.12.003","article-title":"Exosome Secreted by MSC Reduces Myocardial Ischemia\/Reperfusion Injury","volume":"4","author":"Lai","year":"2010","journal-title":"Stem Cell Res."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.scr.2013.01.002","article-title":"Mesenchymal Stem Cell-Derived Exosomes Increase ATP Levels, Decrease Oxidative Stress and Activate PI3K\/Akt Signalling to Enhance Myocardial Viability and Prevent Adverse Remodelling after Myocardial Ischaemia\/Reperfusion Injury","volume":"10","author":"Arslan","year":"2013","journal-title":"Stem Cell Res."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1093\/eurheartj\/ehv136","article-title":"Bone marrow-derived mesenchymal stromal cell treatment in patients with severe ischaemic heart failure: A randomized placebo-controlled trial (MSC-HF trial)","volume":"36","author":"Mathiasen","year":"2015","journal-title":"Eur. Heart J."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1186\/s12967-019-2110-1","article-title":"Autologous adipose-derived stromal cell treatment for patients with refractory angina (MyStromalCell Trial): 3-year follow-up results","volume":"17","author":"Qayyum","year":"2019","journal-title":"J. Transl. Med."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"205","DOI":"10.3727\/096368916X692933","article-title":"ALLogeneic Heart STem Cells to Achieve Myocardial Regeneration (ALLSTAR) Trial: Rationale and Design","volume":"26","author":"Chakravarty","year":"2017","journal-title":"Cell Transplant."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Carta-Bergaz, A., R\u00edos-Mu\u00f1oz, G.R., Cris\u00f3stomo, V., S\u00e1nchez-Margallo, F.M., Ledesma-Carbayo, M.J., Bermejo-Thomas, J., Fern\u00e1ndez-Avil\u00e9s, F., and Arenal-Ma\u00edz, \u00c1. (2022). Intrapericardial cardiosphere-derived cells hinder epicardial dense scar expansion and promote electrical homogeneity in a porcine post-infarction model. Front. Physiol., 13.","DOI":"10.3389\/fphys.2022.1041348"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"3451","DOI":"10.1093\/eurheartj\/ehaa541","article-title":"Intracoronary ALLogeneic heart STem cells to Achieve myocardial Regeneration (ALLSTAR): A randomized, placebo-controlled, double-blinded trial","volume":"41","author":"Makkar","year":"2020","journal-title":"Eur. Heart J."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1186\/s13287-025-04664-0","article-title":"Human induced pluripotent stem cell-derived cardiomyocytes improve recovery from myocardial infarction in non-human primates","volume":"16","author":"Guan","year":"2025","journal-title":"Stem Cell Res. Ther."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"101985","DOI":"10.1016\/j.jcyt.2025.09.008","article-title":"The emerging promise of induced pluripotent stem cells in clinical studies: A systematic scoping review","volume":"28","author":"Thomas","year":"2025","journal-title":"Cytotherapy"},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Yu, Y., Tham, S.K., Roslan, F.F., Shaharuddin, B., Yong, Y.K., Guo, Z., and Tan, J.J. (2023). Large animal models for cardiac remuscularization studies: A methodological review. Front. Cardiovasc. Med., 10.","DOI":"10.3389\/fcvm.2023.1011880"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.stemcr.2019.04.005","article-title":"Human Embryonic Stem Cell-Derived Cardiomyocytes Regenerate the Infarcted Pig Heart but Induce Ventricular Tachyarrhythmias","volume":"12","author":"Romagnuolo","year":"2019","journal-title":"Stem Cell Rep."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s13287-024-03690-8","article-title":"Pre-clinical evaluation of the efficacy and safety of human induced pluripotent stem cell-derived cardiomyocyte patch","volume":"15","author":"Miyagawa","year":"2024","journal-title":"Stem Cell Res. Ther."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"107643","DOI":"10.1016\/j.vascn.2025.107643","article-title":"Electrophysiological maturation of human induced pluripotent stem cell-derived cardiomyocytes","volume":"133","author":"Correia","year":"2025","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"14399","DOI":"10.1038\/s41598-025-97676-y","article-title":"Maturation of human induced pluripotent stem cell-derived cardiomyocytes promoted by Brachyury priming","volume":"15","author":"Kargaran","year":"2025","journal-title":"Sci. Rep."},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Sterckel, S., Passier, R., and Rivera-Arbelaez, J.M. (2025). Electrical stimulation: A missing key to promote maturation of human pluripotent stem cell-derived cardiomyocytes in three-dimensional cardiac tissues. Front. Bioeng. Biotechnol., 13.","DOI":"10.3389\/fbioe.2025.1686342"},{"key":"ref_48","first-page":"1","article-title":"Case report of cell-sheet therapy for cardiomyopathy using iPSC-derived cardiomyocytes","volume":"7","author":"Miyagawa","year":"2022","journal-title":"NPJ Regen. Med."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/s41586-024-08463-0","article-title":"Engineered heart muscle allografts for heart repair in primates and humans","volume":"639","author":"Jebran","year":"2025","journal-title":"Nature"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/s41536-017-0024-1","article-title":"Translational cardiac stem cell therapy: Advancing from first-generation to next-generation cell types","volume":"2","author":"Cambria","year":"2017","journal-title":"NPJ Regen. Med."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"4150705","DOI":"10.1155\/2017\/4150705","article-title":"miRNA-Sequence Indicates That Mesenchymal Stem Cells and Exosomes Have Similar Mechanism to Enhance Cardiac Repair","volume":"2017","author":"Shao","year":"2017","journal-title":"BioMed Res. Int."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"6163","DOI":"10.7150\/thno.28021","article-title":"Hypoxia-Elicited Mesenchymal Stem Cell-Derived Exosomes Facilitate Cardiac Repair through miR-125b-Mediated Prevention of Cell Death in Myocardial Infarction","volume":"8","author":"Zhu","year":"2018","journal-title":"Theranostics"},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Wiewiorska-Krata, N., Foroncewicz, B., Mucha, K., and Zagozdon, R. (2025). Cell therapies for immune-mediated disorders. Front. Med., 12.","DOI":"10.3389\/fmed.2025.1550527"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"e2022091118","DOI":"10.1073\/pnas.2022091118","article-title":"Hypoimmune induced pluripotent stem cell-derived cell therapeutics treat cardiovascular and pulmonary diseases in immunocompetent allogeneic mice","volume":"118","author":"Deuse","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"9238","DOI":"10.1038\/s41598-019-45684-0","article-title":"A comprehensive, multiscale framework for evaluation of arrhythmias arising from cell therapy in the whole post-myocardial infarcted heart","volume":"9","author":"Yu","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.conctc.2018.08.001","article-title":"Factors associated with clinical trials that fail and opportunities for improving the likelihood of success: A review","volume":"11","author":"Fogel","year":"2018","journal-title":"Contemp. Clin. Trials Commun."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"15563316251361511","DOI":"10.1177\/15563316251361511","article-title":"Ethical and Regulatory Considerations Related to Regenerative Medicine","volume":"21","author":"Jayaram","year":"2025","journal-title":"HSS J."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1015996","DOI":"10.1155\/2022\/1015996","article-title":"Ethical challenges and controversies in the practice and advancement of gene therapy","volume":"2022","author":"Ansah","year":"2022","journal-title":"Adv. Cell Gene Ther."},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Muslem, S., AlTurani, M., Maqsood, M.B., and Qaseer, M.A. (2025). Cardiac Repair and Clinical Outcomes of Stem Cell Therapy in Heart Failure: A Systematic Review and Meta-Analysis. Diseases, 13.","DOI":"10.3390\/diseases13050136"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"3702","DOI":"10.1093\/eurheartj\/ehaa651","article-title":"The effect of intracoronary infusion of bone marrow-derived mononuclear cells on all-cause mortality in acute myocardial infarction: The BAMI trial","volume":"41","author":"Mathur","year":"2020","journal-title":"Eur. Heart J."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.ahj.2018.03.016","article-title":"The CardiAMP Heart Failure trial: A randomized controlled pivotal trial of high-dose autologous bone marrow mononuclear cells using the CardiAMP cell therapy system in patients with post-myocardial infarction heart failure: Trial rationale and study design","volume":"201","author":"Raval","year":"2018","journal-title":"Am. Heart J."},{"key":"ref_62","unstructured":"(2026, June 08). Phase I\/II Clinical Trial of Human Allogeneic Culture-Expanded Bone Marrow-Derived Mesenchymal Stem Cells (hMSCs) in Patients with Ischemic Heart Failure with Reduced Ejection Fraction (HFrEF). ClinicalTrials.gov Identifier NCT05915608, Registered 20 June 2023, Available online: https:\/\/clinicaltrials.gov\/study\/NCT05925608."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"e003301","DOI":"10.1136\/openhrt-2025-003301","article-title":"Safety and efficacy of stem cell therapy in acute myocardial infarction: A systematic review and meta-analysis","volume":"12","author":"Moeswir","year":"2025","journal-title":"Open Heart"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1186\/1479-5876-9-183","article-title":"Safety and feasibility of percutaneous retrograde coronary sinus delivery of autologous bone marrow mononuclear cell transplantation in patients with chronic refractory angina","volume":"9","author":"Tuma","year":"2011","journal-title":"J. Transl. Med."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.5966\/sctm.2015-0070","article-title":"REVIVE Trial: Retrograde Delivery of Autologous Bone Marrow in Patients with Heart Failure","volume":"4","author":"Patel","year":"2015","journal-title":"Stem Cells Transl. Med."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"I150","DOI":"10.1161\/CIRCULATIONAHA.104.526749","article-title":"Radiolabeled Cell Distribution After Intramyocardial, Intracoronary, and Interstitial Retrograde Coronary Venous Delivery: Implications for Current Clinical Trials","volume":"112","author":"Hou","year":"2005","journal-title":"Circulation"},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Khanna, A., Zamani, M., and Huang, N.F. (2021). Extracellular Matrix-Based Biomaterials for Cardiovascular Tissue Engineering. J. Cardiovasc. Dev. Dis., 8.","DOI":"10.3390\/jcdd8110137"},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Roacho-Perez, J.A., Garza-Trevino, E.N., Moncada-Saucedo, N.K., Carriquiry-Chequer, P.A., Valencia-G\u00f3mez, L.E., Matthews, E.R., G\u00f3mez-Flores, V., Simental-Mend\u00eda, M., Delgado-Gonzalez, P., and Delgado-Gallegos, J.L. (2022). Artificial Scaffolds in Cardiac Tissue Engineering. Life, 12.","DOI":"10.20944\/preprints202203.0305.v1"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"e12942","DOI":"10.1111\/cpr.12942","article-title":"Hyaluronate supports hESC-cardiomyocyte cell therapy for cardiac regeneration after acute myocardial infarction","volume":"53","author":"Tan","year":"2020","journal-title":"Cell Prolif."},{"key":"ref_70","doi-asserted-by":"crossref","unstructured":"Kim, Y., Zharkinbekov, Z., Sarsenova, M., Yeltay, G., and Saparov, A. (2021). Recent Advances in Gene Therapy for Cardiac Tissue Regeneration. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22179206"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1093\/cvr\/cvaf109","article-title":"Gene therapy in cardiac and vascular diseases","volume":"121","author":"Musolino","year":"2025","journal-title":"Cardiovasc. Res."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.ymthe.2021.10.015","article-title":"CRISPR activation of endogenous genes reprograms fibroblasts into cardiovascular progenitor cells for myocardial infarction therapy","volume":"30","author":"Jiang","year":"2022","journal-title":"Mol. Ther."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1161\/CIRCRESAHA.112.300625","article-title":"Direct Cardiac Reprogramming","volume":"113","author":"Qian","year":"2013","journal-title":"Circ. Res."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1038\/nprot.2013.067","article-title":"Reprogramming of mouse fibroblasts into cardiomyocyte-like cells in vitro","volume":"8","author":"Qian","year":"2013","journal-title":"Nat. Protoc."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s41536-025-00394-2","article-title":"Revitalizing the heart: Strategies and tools for cardiomyocyte regeneration post-myocardial infarction","volume":"10","author":"Bois","year":"2025","journal-title":"NPJ Regen. Med."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/s41392-025-02313-9","article-title":"Mesenchymal stem cells in treating human diseases: Molecular mechanisms and clinical studies","volume":"10","author":"Han","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.yjmcc.2014.12.011","article-title":"A systematic analysis of neonatal mouse heart regeneration after apical resection","volume":"79","author":"Bryant","year":"2015","journal-title":"J. Mol. Cell. Cardiol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1126\/science.abm0594","article-title":"CAR T cells produced in vivo to treat cardiac injury","volume":"375","author":"Rurik","year":"2022","journal-title":"Science"},{"key":"ref_79","doi-asserted-by":"crossref","unstructured":"Bonowicz, K., Jerka, D., Piekarska, K., Olagbaju, J., Stapleton, L., Shobowale, M., and Gagat, M. (2025). CRISPR-Cas9 in cardiovascular medicine: Unlocking new potential for treatment. Cells, 14.","DOI":"10.3390\/cells14020131"},{"key":"ref_80","doi-asserted-by":"crossref","unstructured":"Wu, J., Shi, Y., Han, S., and Yang, X. (2025). Efficacy and clinical outcomes of bone-marrow mononuclear cell therapy in chronic heart failure: A systemic review and meta-analysis. BMC Cardiovasc. Disord., 25.","DOI":"10.1186\/s12872-025-04938-8"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1097\/FJC.0000000000001707","article-title":"Gene- and cell-based therapy in cardiovascular diseases","volume":"86","author":"Zhang","year":"2025","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"ref_82","first-page":"313","article-title":"Immunomodulatory Functions of Mesenchymal Stem Cells in Tissue Engineering","volume":"80","author":"Amirhossein","year":"2025","journal-title":"Arch. Razi Inst."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1186\/s13287-025-04678-8","article-title":"Stem cell therapy for myocardial infarction and atherosclerosis: Mechanisms, challenges, and future directions","volume":"16","author":"Wan","year":"2025","journal-title":"Stem Cell Res. Ther."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/s43856-025-00963-y","article-title":"Reprogramming of human urine cells into cardiomyocytes via a small molecule cocktail in xeno-free conditions","volume":"5","author":"Chen","year":"2025","journal-title":"Commun. Med."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"36","DOI":"10.7150\/ijms.21666","article-title":"Ethical and Safety Issues of Stem Cell-Based Therapy","volume":"15","author":"Volarevic","year":"2018","journal-title":"Int. J. Med. Sci."},{"key":"ref_86","first-page":"e471","article-title":"Gene therapy in cardiovascular disease: Recent advances and future directions","volume":"150","author":"Kim","year":"2024","journal-title":"Circulation"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"2867","DOI":"10.1016\/j.devcel.2023.10.012","article-title":"Transcription factor NFYa controls cardiomyocyte metabolism and proliferation during mouse fetal heart development","volume":"58","author":"Cui","year":"2023","journal-title":"Dev. Cell"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"e70407","DOI":"10.1002\/mco2.70407","article-title":"Heart Regeneration and Repair: Molecular Mechanism and Therapeutic Targets","volume":"6","author":"Liu","year":"2025","journal-title":"MedComm"},{"key":"ref_89","unstructured":"(2026, June 08). A Study of iPS Cell-Derived Cardiomyocyte Spheroids (HS-001) in Patients with Heart Failure (LAPiS Study). ClinicalTrials.gov Identifier NCT04945018, Registered 25 June 2021. Available online: https:\/\/www.trialx.com\/clinical-trials\/listings\/261302\/a-study-of-ips-cell-derived-cardiomyocyte-spheroids-hs-001-in-patients-with-heart-failure-lapis-study\/."}],"container-title":["Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2079-7737\/15\/15\/1260\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T13:41:04Z","timestamp":1785505264000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2079-7737\/15\/15\/1260"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,31]]},"references-count":89,"journal-issue":{"issue":"15","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["biology15151260"],"URL":"https:\/\/doi.org\/10.3390\/biology15151260","relation":{},"ISSN":["2079-7737"],"issn-type":[{"value":"2079-7737","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,31]]}}}